Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunologic risk factors for chronic renal allograft dysfunction.

L C Paul1

  • 1Leiden University Medical School, The Netherlands.

Transplantation
|October 5, 2001
PubMed
Summary

Tissue injury is central to chronic allograft dysfunction (CRAD), potentially involving immune responses to exposed antigens. Preventing tissue damage, particularly through appropriate immunosuppression, is key to managing CRAD risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cyclosporine-induced renal dysfunction.

Transplantation proceedings·2004
Same author

Dietary intake, eating behavior, and physical activity-related determinants of high body mass index in rural communities in Wyoming, Montana, and Idaho.

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·2003
Same author

Pharmacotherapeutic approach to prevent or treat chronic allograft nephropathy.

Current drug targets. Cardiovascular & haematological disorders·2003
Same author

Renal disease in relatives of Indo-Asian Type 2 diabetic patients with end-stage diabetic nephropathy.

Diabetologia·2003
Same author

Redefining expectations in transplantation: minimizing side effects, maximizing quality of life. Introduction.

Transplantation·2002
Same author

Risk factors that influence the intercept or the slope of graft function over time.

Transplantation proceedings·2001

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Pathology

Background:

  • Chronic allograft dysfunction (CRAD) is a major cause of kidney transplant failure.
  • Tissue injury, from immunological or non-immunological factors, is a central feature of CRAD.
  • Immune responses to exposed cryptic antigens can exacerbate tissue damage in allogeneic transplantation.

Purpose of the Study:

  • To explore the role of tissue injury and immune responses in the development of CRAD.
  • To investigate the association between HLA mismatches, antibodies, and CRAD.
  • To identify strategies for preventing CRAD, focusing on minimizing tissue damage and optimizing immunosuppression.

Main Methods:

  • Review of clinical studies and animal models investigating CRAD pathogenesis.

Related Experiment Videos

  • Analysis of the role of HLA mismatches and donor-specific antibodies (anti-HLA, anti-B cell).
  • Examination of antibody responses against various kidney tissue components in animal models.

    • Main Results:

    • Tissue injury is a primary driver of CRAD, with immune responses potentially amplifying damage.
    • While HLA mismatches are implicated, clinical data on their increasing risk for CRAD is inconsistent.
    • Antibodies against HLA and other donor-specific antigens are associated with CRAD in human studies.
    • Animal models show antibody production against glomerular, tubular, and vascular antigens, but their role in human CRAD is uncertain.

    Conclusions:

    • Preventing tissue damage, especially immune-mediated injury, is crucial for CRAD prevention.
    • Maintaining adequate immunosuppression and considering non-nephrotoxic agents are vital strategies.
    • Further research is needed to elucidate the role of specific antibody responses in human CRAD.